| 1. |
Yaghmai R. and Hazelbauer G. L. (1992) Ligand occupancy mimicked by single residue substitutions in a receptor: transmembrane
signaling induced by mutation. Proc. Natl. Acad, Sci. USA
89, 7890–7894.
|
| |
| 2. |
Ohphant A. R. and Struhl K. (1989) An efficient method for generating proteins with altered enzymatic properties: application
to β-lactamase. Proc. Natl. Acad SCL USA
86, 9094–9098.
|
| |
| 3. |
Arkin A. P. and Youvan D. C. (1992) Optimizing nucleotide mixtures to encode specific subsets of amino acids for semi-random
mutagenesis Bzorechnologv
10, 297–300.
|
| |
| 4. |
Burstein E. S., Spalding T A, Hill-Eubanks D, and Brann M. R. (1995) Structurefunction of muscarimc receptor coupling to G
proteins. J Biol. Chem
270, 3141–3146.
|
| |
| 5. |
Hill-Eubanks D., Burstem E. S., Spalding T. A., Brauner-Osborne H., and Brann M. R. (1996) Structure of a G-protein-coupling
domain of a muscarinic receptor predicted by random saturation mutagenesis. J. Biol Chem.
271, 3058–3065.
|
| |
| 6. |
Spalding T. A., Burstein E. S., Bröuner-Osborne H., Hill-Eubanks D, and Brann M. R. (1995) Pharmacology of a constitutively
active muscarmic receptor generated by random mutagenesis. J. Pharmacol. Exp Ther.
275, 1274–1279.
|
| |
| 7. |
Burstein E. S., Spalding T. A., and Brann M. R. (1996) Amino acid side chams that define muscarinic receptor/G-protein couplmg.
Studies of the third intracellular loop. J. Blol. Chem.
271, 2882–2885.
|
| |
| 8. |
Gutkind J. S., Novotny E. A., Brann M. R., and Robbins K. C. (1991) Muscarinic acetylcholine receptor subtypes as agonist-dependent
oncogenes. Proc Natl Acad. Sci. USA
88, 4703–4707.
|
| |
| 9. |
Brauner-Osborne H. and Brann M. R. (1996) Pharmacology of muscarinic acetylcholine receptor subtypes (ml–m5): high throughput
assays in mammalian cells. Eur. J. Pharmacol
295, 93–102.
|
| |
| 10. |
Messier T. L., Dorman C. M., Bröuner-Osborne H., Eubanks D., and Brann M. R. (1995) High throughput assays of cloned adrenergic,
muscarinic, neurokimn, and neurotrophin receptors in living mammalian cells. Pharmacol Toxicol. 76, 30–311.
|
| |
| 11. |
Wigler M., Silverstein S., Lee L.-S., Pellicer A., Cheng Y.-C., and Axel R (1977) Transfer of purified herpes virus thymidine
kinase gene to cultured mouse cells. Cell
11, 223–232.
|
| |
| 12. |
Lim K. and Chae C.-B. (1989) A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates
for β-galactosidase. BioTechniques
7, 576–579.
|
| |
| 13. |
Hermes J. D., Blacklow S. C., and Knowles J. R. (1990) Searching sequence space by definably random mutagenesis: improving
the catalytic potency of an enzyme. Proc. Natl. Acad Scl USA
87, 696–700.
|
| |
| 14. |
Murray R., Pederson K., Prosser H., Muller D., Hutchison C. A., 3d, and Frelinger J. A. (1988) Random oligonucleotide mutagenesis:
application to a large protein coding sequence of a major histocompatibility complex class I gene, H-2DP. Nucl. Acids Res.
16, 9761–9763.
|
| |
| 15. |
Derbyshire K. M., Salvo J. J., and Grindley N. D. (1986) A simple and efficient procedure for saturation mutagenesis using
mixed oligodeoxynucleotides. Gene
46, 145–152.
|
| |
| 16. |
Sambrook J. (1989) Moleculur Clonzng, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
|
| |
| 17. |
Burstein E. S., Spalding T. A., and Brann M. R. (1996) Constitutive activation of chimeric m2/m5 muscarmlc receptors and delineation
of G-protein coupling selectivity domains. Biochem Pharmacol. 51, 539–544.
|
| |
| 18. |
Burstem E. S., Spaldmg T. A., Bröuner-Osborne H., and Brann M. R. (1995) Constitutive activation of muscarinic receptors by
the G-protein Gq. FEBS Lett.
363, 26l–263.
|
| |